Veru (VERU) Stock Price, Quote, News & History | Benzinga

Veru Inc (VERU) Stock Price, Quote, News & History

VERUNASDAQ

Trade with Public

Trade with Public

$2.73

0.031.11%

At close: Aug 14, 5:00 PM EST

$2.69

-0.04-1.47%

After Hours: Aug 14, 4:57 PM EST

Earnings: Q3 2026 Earnings were released on Mon Aug 10th, before the market open

Conference Call: The most recent conference call started at 8:00 AM, 5 days ago

Click to view the webcast

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$2.70

Close

$2.73

Volume / Avg.

159.10K / 1.97M

Day Range

$2.64 - $2.76

52 Wk Range

2.05 - 7.33

Market Cap

$45.87M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

58

Short Interest

8.96%

Days to Cover

6.6

Recent Veru Inc. News

Top Wall Street Forecasters Revamp Veru Expectations Ahead Of Q4 Earnings

Avi Kapoor

Top Stocks With Earnings This Week: Micron, FuelCell, Carnival and More

Investors are prepping for this week's earnings reports which include homebuilders, several apparel companies and a big tech company.

Erica Kollmann

Eli Lilly Ends Bimagrumab Obesity Study Weeks After Launch

On Wednesday, Eli Lilly & Co. (NYSE: LLY) ended a mid-stage study of its experimental drug bimagrumab in obesity patients with type 2 diabetes, just weeks after it began.

Vandana Singh

Veru's Enobosarm Shows Muscle In Wegovy Combo Trial

Veru reports strong safety and efficacy for enobosarm added to semaglutide, showing reduced functional decline and muscle loss in older adults.

Vandana Singh

S&P 500 Falls Over 100 Points; Dada Nexus Shares Spike Higher

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-26.04M

Investing Cash Flow (TTM)

11.60M

Financing Cash Flow (TTM)

23.31M

Free Cash Flow (TTM)

-26.04M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

8.87M

Analyst Trends and Forecast

1

May

1

Jun

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$23.61M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

1.62

Earnings Yield % (TTM)

-22.68%

Earnings Yield % (FWD)

-42.01%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$1.66

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$23.88M

Debt to Equity

0.09

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$2.70

Close

$2.73

Volume / Avg.

159.10K / 1.97M

Day Range

$2.64 - $2.76

52 Wk Range

2.05 - 7.33

Market Cap

$45.87M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

58

Short Interest

8.96%

Days to Cover

6.6

About

Sector

Health Care

Industry

Pharmaceuticals

Veru Inc is a late clinical-stage biopharmaceutical focused on developing medicines for the treatment of cardiometabolic and inflammatory diseases. Its drug development program consists of two late-stage new chemical entities, enobosarm and sabizabul...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Veru (VERU) stock?

A

You can purchase shares of Veru (NASDAQ:VERU) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Veru (VERU) competitors?

A

Other companies in Veru’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).

Q

What is the forecast, or price target, for Veru (VERU) stock?

A

Veru has a consensus price target of $15.40.

Q

What is the current price for Veru (VERU)?

A

The stock price for Veru (NASDAQ: VERU) is $2.69 last updated August 14, 2026 at 4:57 PM EDT.

Q

Does Veru (VERU) pay a dividend?

A

There are no upcoming dividends for Veru.

Q

When is Veru (NASDAQ:VERU) reporting earnings?

A

Veru does not have any upcoming earnings scheduled.

Q

Is Veru (VERU) going to split?

A

There is no upcoming split for Veru.

Q

What sector and industry does Veru (VERU) operate in?

A

Veru is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.